Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$1.85 USD
+0.01 (0.54%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $1.87 +0.02 (1.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.85 USD
+0.01 (0.54%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $1.87 +0.02 (1.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Zacks News
Best Momentum Stocks to Buy for July 12th
by Zacks Equity Research
RMTI, ZUO and OPK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 12, 2023.
New Strong Buy Stocks for July 12th
by Zacks Equity Research
SOHO, PD, RMTI, TEF and ZUO have been added to the Zacks Rank #1 (Strong Buy) List on July 12, 2023.
Rockwell Medical (RMTI) Soars 20.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Rockwell Medical (RMTI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
What Makes Rockwell Medical (RMTI) a Good Fit for 'Trend Investing'
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Bruker (BRKR) Introduces the D6 PHASER Benchtop XRD Platform
by Zacks Equity Research
Bruker's (BRKR) new D6 PHASER platform is to be used for material analysis and advanced research.
What Makes Rockwell Medical (RMTI) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Rockwell Medical (RMTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Haemonetics (HAE) Gets FDA Clearance for NexSys PCS Upgrades
by Zacks Equity Research
Haemonetics (HAE) receives FDA clearance for the advancements made to the NexSys PCS plasma collection system.
Beat the Market Like Zacks: NVIDIA, VirTra, Rockwell Medical in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
by Zacks Equity Research
Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Rockwell Medical (RMTI) Is Still a Bargain Stock
by Zacks Equity Research
Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 44.44% and 4.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Gritstone bio Inc. (GRTS) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 6.25% and 38.93%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
PetIQ (PETQ) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 28.57% and 4.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Insulet (PODD) delivered earnings and revenue surprises of 155.56% and 8.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Palo Alto Networks and RH have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Palo Alto Networks and RH are part of the Zacks Bull and Bear of the Day article.
3 Medical Product Stocks With Strong Potential to Gain in 2023
by Indrajit Bandyopadhyay
Here we discuss three medical instruments stocks, LNTH, RMTI and VMD, which are witnessing solid momentum in 2023. These stocks have the potential to continue their uptrend going forward.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Rockwell Medical (RMTI)
by Zacks Equity Research
Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Beat the Market the Zacks Way: NVIDIA, Bilibili, Novo Nordisk in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Capricor (CAPR) delivered earnings and revenue surprises of 7.14% and 279.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
IM Cannabis Corp. (IMCC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
IM Cannabis Corp. (IMCC) delivered earnings and revenue surprises of -550% and 6.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Perrigo (PRGO) Q1 Earnings Lag Estimates
by Zacks Equity Research
Perrigo (PRGO) delivered earnings and revenue surprises of -21.43% and 1.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?